Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
US7498414 | NA | Human antibodies specific to KDR and uses thereof |
Jan, 2026
(2 years from now) |
Ingredients: RAMUCIRUMAB
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic